Loading...
Header Logo
Keywords
Last Name
Institution

SOUNG-CHUL CHA

TitleAssistant Professor
InstitutionMD Anderson
DepartmentLymphoma-Myeloma
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Verify Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Liu Y, Wei G, Cheng WA, Dong Z, Sun H, Lee VY, Cha SC, Smith DL, Kwak LW, Qin H. Targeting myeloid-derived suppressor cells for cancer immunotherapy. Cancer Immunol Immunother. 2018 Aug; 67(8):1181-1195. PMID: 29855694.
      View in: PubMed
    2. Thomas SK, Cha SC, Smith DL, Kim KH, Parshottam SR, Rao S, Popescu M, Lee VY, Neelapu SS, Kwak LW. Phase I study of an active immunotherapy for asymptomatic phase Lymphoplasmacytic lymphoma with DNA vaccines encoding antigen-chemokine fusion: study protocol. BMC Cancer. 2018 02 13; 18(1):187. PMID: 29439670.
      View in: PubMed
    3. Qin H, Wei G, Sakamaki I, Dong Z, Cheng WA, Smith DL, Wen F, Sun H, Kim K, Cha S, Bover L, Neelapu SS, Kwak LW. Novel BAFF-Receptor Antibody to Natively Folded Recombinant Protein Eliminates Drug-Resistant Human B-cell Malignancies In Vivo. Clin Cancer Res. 2018 03 01; 24(5):1114-1123. PMID: 29180606.
      View in: PubMed
    4. Weng J, Baio FE, Moriarty KE, Torikai H, Wang H, Liu Z, Maiti SN, Gwak D, Popescu MS, Cha SC, Cooper LJ, Neelapu SS, Kwak LW. Targeting B-cell malignancies through human B-cell receptor specific CD4+ T cells. Oncoimmunology. 2016; 5(11):e1232220. PMID: 27999743.
      View in: PubMed
    5. Qin H, Lerman B, Sakamaki I, Wei G, Cha SC, Rao SS, Qian J, Hailemichael Y, Nurieva R, Dwyer KC, Roth J, Yi Q, Overwijk WW, Kwak LW. Generation of a new therapeutic peptide that depletes myeloid-derived suppressor cells in tumor-bearing mice. Nat Med. 2014 Jun; 20(6):676-81. PMID: 24859530.
      View in: PubMed
    6. Cha SC, Qin H, Sakamaki I, Kwak L. Cloning variable region genes of clonal lymphoma immunoglobulin for generating patient-specific idiotype DNA vaccine. Methods Mol Biol. 2014; 1139:289-303. PMID: 24619688.
      View in: PubMed
    7. Sakamaki I, Kwak LW, Cha SC, Yi Q, Lerman B, Chen J, Surapaneni S, Bateman S, Qin H. Lenalidomide enhances the protective effect of a therapeutic vaccine and reverses immune suppression in mice bearing established lymphomas. Leukemia. 2014 Feb; 28(2):329-37. PMID: 23765229.
      View in: PubMed
    8. Cha SC, Qin H, Kannan S, Rawal S, Watkins LS, Baio FE, Wu W, Ong J, Wei J, Kwak B, Kim S, Popescu MS, Paick DS, Kim K, Luong A, Davis RE, Schroeder HW, Kwak LW, Neelapu SS. Nonstereotyped lymphoma B cell receptors recognize vimentin as a shared autoantigen. J Immunol. 2013 May 01; 190(9):4887-98. PMID: 23536634.
      View in: PubMed
    9. Weng J, Cha SC, Matsueda S, Alatrash G, Popescu MS, Yi Q, Molldrem JJ, Wang M, Neelapu SS, Kwak LW. Targeting human B-cell malignancies through Ig light chain-specific cytotoxic T lymphocytes. Clin Cancer Res. 2011 Sep 15; 17(18):5945-52. PMID: 21813633.
      View in: PubMed
    10. Park HJ, Qin H, Cha SC, Sharma R, Chung Y, Schluns KS, Neelapu SS, Overwijk WW, Hwu P, Kwak LW. Induction of TLR4-dependent CD8+ T cell immunity by murine ß-defensin2 fusion protein vaccines. Vaccine. 2011 Apr 18; 29(18):3476-82. PMID: 21382485.
      View in: PubMed
    11. Qin H, Cha SC, Neelapu SS, Liu C, Wang YH, Wei J, Qin XF, Liu YJ, Kwak LW. Generation of an immune microenvironment as a novel mechanism for myotoxins to potentiate genetic vaccines. Vaccine. 2010 Nov 23; 28(50):7970-8. PMID: 20937320.
      View in: PubMed
    12. Qin H, Nehete PN, He H, Nehete B, Buchl S, Cha SC, Sastry JK, Kwak LW. Prime-boost vaccination using chemokine-fused gp120 DNA and HIV envelope peptides activates both immediate and long-term memory cellular responses in rhesus macaques. J Biomed Biotechnol. 2010; 2010:860160. PMID: 20454526.
      View in: PubMed
    13. Qin H, Cha SC, Neelapu SS, Lou Y, Wei J, Liu YJ, Kwak LW. Vaccine site inflammation potentiates idiotype DNA vaccine-induced therapeutic T cell-, and not B cell-, dependent antilymphoma immunity. Blood. 2009 Nov 05; 114(19):4142-9. PMID: 19749091.
      View in: PubMed
    14. Zhu K, Qin H, Cha SC, Neelapu SS, Overwijk W, Lizee GA, Abbruzzese JL, Hwu P, Radvanyi L, Kwak LW, Chang DZ. Survivin DNA vaccine generated specific antitumor effects in pancreatic carcinoma and lymphoma mouse models. Vaccine. 2007 Nov 14; 25(46):7955-61. PMID: 17933439.
      View in: PubMed
    15. Kobrin C, Cha SC, Qin H, Raffeld M, Fend F, Quintanilla-Martinez L, Grove S, Jaffe ES, Kwak LW. Molecular analysis of light-chain switch and acute lymphoblastic leukemia transformation in two follicular lymphomas: implications for lymphomagenesis. Leuk Lymphoma. 2006 Aug; 47(8):1523-34. PMID: 16966263.
      View in: PubMed
    16. Neelapu SS, Lee ST, Qin H, Cha SC, Woo AF, Kwak LW. Therapeutic lymphoma vaccines: importance of T-cell immunity. Expert Rev Vaccines. 2006 Jun; 5(3):381-94. PMID: 16827622.
      View in: PubMed
    17. Pai Kasturi S, Qin H, Thomson KS, El-Bereir S, Cha SC, Neelapu S, Kwak LW, Roy K. Prophylactic anti-tumor effects in a B cell lymphoma model with DNA vaccines delivered on polyethylenimine (PEI) functionalized PLGA microparticles. J Control Release. 2006 Jul 20; 113(3):261-70. PMID: 16793161.
      View in: PubMed
    18. Cha SC, Kwak LW, Ruffini PA, Qin H, Neelapu S, Biragyn A. Cloning of B cell lymphoma-associated antigens using modified phage-displayed expression cDNA library and immunized patient sera. J Immunol Methods. 2006 May 30; 312(1-2):79-93. PMID: 16631194.
      View in: PubMed
    19. Ruffini PA, Biragyn A, Coscia M, Harvey LK, Cha SC, Bogen B, Kwak LW. Genetic fusions with viral chemokines target delivery of nonimmunogenic antigen to trigger antitumor immunity independent of chemotaxis. J Leukoc Biol. 2004 Jul; 76(1):77-85. PMID: 15075363.
      View in: PubMed
    20. Lee HH, Cha SC, Jang DJ, Lee JK, Choo DW, Kim YS, Uh HS, Kim SY. Immunization with combined HSV-2 glycoproteins B2 : D2 gene DNAs: protection against lethal intravaginal challenges in mice. Virus Genes. 2002 Oct; 25(2):179-88. PMID: 12416680.
      View in: PubMed
    21. Cha SC, Kim YS, Cho JK, Cho J, Kim SY, Kang H, Cho MH, Lee HH. Enhanced protection against HSV lethal challenges in mice by immunization with a combined HSV-1 glycoprotein B:H:L gene DNAs. Virus Res. 2002 Jun; 86(1-2):21-31. PMID: 12076826.
      View in: PubMed
    22. Expression of the HSV-1 (F) glycoprotein B gene in insect cells infected by HcNPV recombinant. Journal of Microbiology and Biotechnology. 10:355-362.
    23. Overexpression of insecticidal protein gene of Bacillus thuringiensis var. kurstaki HD1. Journal of Microbiology. 36:289-295.
    24. High Level Production of Glycoprotein H of HSV-1 (F) Using HcNPV Vector System. Journal of Biochemistry and Molecular Biology. 33:483-492.
    25. Targeting B-cell malignancies through human B-cell receptor specific CD4+ T cells. OncoImmunology. 5.
    26. Construction of a baculovirus expression system using Hyphantria cunea nuclear polyhedrosis virus for eukaryotic cells. Journal of Microbiology and Biotechnology. 8:676-684.
    27. Construction of a baculovirus Hyphantria cunea NPV insecticide containing the insecticidal protein gene of Bacillus thuringiensis subsp. kurstaki HD1. Journal of Microbiology and Biotechnology. 8:685-691.
    28. Expression in Escherichia coli of a cloned Bacillus thuringiensis subsp. kurstaki HD1 insecticidal protein gene. Korean Journal of Applied Microbiology and Biotechnology. 26:497-506.
    CHA's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description